LTBR and hepatocellular carcinoma: Lymphotoxin β receptor (LTBR), a member of the tumor necrosis factor (TNF)/TNF receptor superfamily, significantly affects the activation and clonal expansion of CD8+ T cells and has been found to be associated with the development and progression of hepatocellular carcinoma (Zhu et al., 2017).